Merck ends acquisition talks with Revolution Medicines - WSJ

January 25, 2026 2:35 PM UTC Send to a Friend
Merck & Co. (NYSE: MRK) is no longer in discussions to acquire Revolution Medicines Inc. (NASDAQ: RVMD), according to people ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login